Functional analysis of the human complement receptor 2 (CR2/CD21) promoter: Characterization of basal transcriptional mechanisms

被引:21
|
作者
Ulgiati, D
Pham, C
Holers, VM
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Dept Immunol, Denver, CO 80262 USA
[2] Univ Colorado, Hlth Sci Ctr, Div Rheumatol, Dept Med, Denver, CO 80262 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 12期
关键词
D O I
10.4049/jimmunol.168.12.6279
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human complement receptor (CR) type 2 (CR2/CD21) is a 145-kDa membrane protein encoded within the regulators of complement activation gene cluster localized on human chromosome 1q32. Understanding the mechanisms that regulate CR2 expression is important because CR2 is expressed during specific stages of B cell development, and several lines of evidence suggest a role for altered CR2 function or expression in a number of autoimmune diseases. Additionally, even modest changes in CR2 expression are likely to affect relative B cell responses. In this study we have delineated the transcriptional requirements of the human CR2 gene. We have studied the human CR2 proximal promoter and identified sites important for controlling the level of transcription in CR2-expressing cells. We have determined that four functionally relevant sites lie within very close proximity to the transcriptional initiation site. These sites bind the transcription factors USF1, an AP-2-like transcription factor, and Sp1.
引用
收藏
页码:6279 / 6285
页数:7
相关论文
共 50 条
  • [21] Tandem E box motifs control complement receptor 2 (CR2/CD21) promoter activity via a novel repressor protein and chromatin accessibility
    Cruikshank, Mark N.
    Fenwick, Emily J.
    Dods, James
    Holers, V. Michael
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 162 - 162
  • [22] Characterisation of a monoclonal antibody, which recognises preferentially astrocytic CR2/CD21 and recruits CR2/CD21 in lipid rafts for signalling
    Jégou, JF
    Schouft, MT
    Thorel, N
    Bénard, M
    Fontaine, M
    MOLECULAR IMMUNOLOGY, 2006, 43 (1-2) : 148 - 148
  • [23] Changes in chromatin accessibility across the complement receptor 2 (CR2/CD21) gene promoter occurs during different stages of B cell development
    Cruikshank, Mark N.
    Fenwick, Emily J.
    Abraham, Lawrence J.
    Ulgiati, Daniela
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 162 - 162
  • [24] Human complement receptor 2 (CR2/CD21) as a receptor for DNA: Implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)
    Asokan, Rengasamy
    Banda, Nirmal K.
    Szakonyi, Gerda
    Chen, Xiaojiang S.
    Holers, V. Michael
    MOLECULAR IMMUNOLOGY, 2013, 53 (1-2) : 99 - 110
  • [25] ASSOCIATION OF CR2/CD21 POLYMORPHISMS WITH SYSTEMIC SCLEROSIS
    Bonino, C.
    Zorzetto, M.
    Ottaviani, S.
    Cavagna, L.
    Paracchini, E.
    Pozzi, E.
    De Silvestri, A.
    Montecucco, C.
    Luisetti, M.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S140 - S140
  • [26] CD21/CR2的研究进展
    王琳
    免疫学杂志, 2003, (S1) : 100 - 103
  • [27] Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis
    Masilamani, M
    von Kempis, J
    Illges, H
    RHEUMATOLOGY, 2004, 43 (02) : 186 - 190
  • [28] High levels of human complement receptor 2 (CR2, CD21) expression in Cr2-/- mice results in a marked reduction in peripheral B cell numbers
    Marchbank, KJ
    Gibson, M
    Morgan, BP
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 109 - 109
  • [29] Defective B cell ontogeny and immune response are partially reversed in aging human complement receptor 2 (CR2, CD21) transgenic mice
    Kulik, Liudmila
    Holers, V. Michael
    Marchbank, Kevin J.
    MOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 200 - 200
  • [30] Human complement receptor (CR2/CD21) is a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)
    Asokan, R
    Lyubchenko, T
    Szakonyi, G
    Hannan, JP
    Kotzin, BL
    Chen, XS
    Holers, VM
    MOLECULAR IMMUNOLOGY, 2004, 41 (2-3) : 205 - 205